# Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation

> **NCT04113317** · PHASE3 · COMPLETED · sponsor: **Fakultas Kedokteran Universitas Indonesia** · enrollment: 52 (actual)

## Conditions studied

- Liver Cirrhosis
- Severe Malnutrition
- PELD
- Undernutrition

## Interventions

- **DRUG:** G-CSF (Filgrastim)

## Key facts

- **NCT ID:** NCT04113317
- **Lead sponsor:** Fakultas Kedokteran Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04113317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04113317, "Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04113317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*